Acura Pharmaceuticals
ACUR
ACUR was delisted on the 22nd of February, 2017.
33 hedge funds and large institutions have $12.6M invested in Acura Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 9 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 37 → 33 (-4)
26% less capital invested
Capital invested by funds: $17.1M → $12.6M (-$4.47M)
29% less call options, than puts
Call options by funds: $10K | Put options by funds: $14K
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
56% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Creative Planning
Overland Park,
Kansas
|
+$128K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$30.7K |
| 3 |
Renaissance Technologies
New York
|
+$15.4K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$14.6K |
| 5 |
AP
Atwood & Palmer
Kansas City,
Missouri
|
+$6.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CB
Commerce Bank
Kansas City,
Missouri
|
-$131K |
| 2 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$95K |
| 3 |
OC
Oppenheimer & Co
New York
|
-$48.5K |
| 4 |
SIM
Spark Investment Management
New York
|
-$42K |
| 5 |
Morgan Stanley
New York
|
-$40.9K |
ACUR Hedge Fund Activity: Q2 2014 in Review
33 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Acura Pharmaceuticals (ACUR) for Q2 2014, worth a combined $12.6M — down 26% from $17.1M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ACUR and 5 opened new positions — a net loss of 4 holders — while 9 trimmed existing stakes and 4 added.
The largest buyer was Creative Planning, opening a new position worth an estimated $128K. The largest seller was Commerce Bank, exiting entirely with an estimated $131K sold.
- 33 institutional investors held Acura Pharmaceuticals (ACUR) as of Q2 2014, down from 37 in Q1 2014.
- Funds reported $12.6M of Acura Pharmaceuticals stock for Q2 2014, down 26% quarter-over-quarter.
- 5 funds opened new Acura Pharmaceuticals positions in Q2 2014 and 9 closed out, a net change of -4 holders.
- The largest Acura Pharmaceuticals buyer in Q2 2014 was Creative Planning, an estimated $128K added.
- The largest Acura Pharmaceuticals seller in Q2 2014 was Commerce Bank, an estimated $131K sold.
Based on aggregated 13F filings for Q2 2014.